To ascertain that SIRT2 is required for deacetylation and deubiquitination on Fndc5 by NR, we used a SIRT2 selective inhibitor AGK2 in NAFLD model mice. The gene discussed is FNDC5; the disease is metabolic dysfunction-associated steatotic liver disease.